Doctor Blotter, Author at PsyNews.com

Home Authors Posts by Doctor Blotter

4 POSTS 0 COMMENTS

Expanding ketamine’s horizons for rare neurological disorders

William Leonard Pickard participating in celebration for Sasha Shulgin’s new book...

Tryp Therapeutics Partners with Clinlogix for Clinical Trial Support

Henrik Dahl’s Review of Pickard’s ‘The Rose of Paracelsus: On Secrets...

Taking the Leap: Skydiving, Psychedelics, and Unlocking Personal Potential

Psychedelic Alpha’s Top 11 Stories from 2024

Rethinking Addiction and Treatment Models: Is the Recovery Community Ready for...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Doctor Blotter